Metabolic Visceral Fat & Body Composition Phase III trials confirmed significant reductions in visceral adipose tissue in HIV+ adults with abdominal fat accumulation
Archived from the original (PDF) on 2020-08-01
A new study by University of Colorado Anschutz researchers found that of 75 med spas offering compounded GLP-1 drugs across two states, several got their supply from pharmacies that lacked proper licensing
GLP1 and cancer: friend or foe
Chang HC, Huang YC, Lien YJ, Chang YS
In terms of duration of action, exenatide and lixisenatide are considered short-acting GLP-1 receptor agonists with a half-life of approximately 25 h, while dulaglutide, liraglutide and exenatide-LAR are considered long-acting GLP-1 receptor agonists with a half-life of 12 hseveral days